NCT00572611View on ClinicalTrials.gov

Human Mass Balance Study With Bilastine

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Healthy

Interventions

DRUG

[14C]-bilastine

Single oral dose of 20 mg \[14C\]-bilastine. 1 capsule. 1 day dosing only

Trial Locations (1)

EH14 4AP

Charles River Laboratories Clinical Services Ltd, Origo Centre, Riccarton

Sponsors

Lead Sponsor

Faes Farma, S.A.

All Listed Sponsors

collaborator

Charles River Clinical Services Edinburgh Ltd and CR Laboratories Preclinical Services Ltd

UNKNOWN

collaborator

MDS Pharma Services Switzerland AG

UNKNOWN

lead

Faes Farma, S.A.

INDUSTRY

NCT00572611 - Human Mass Balance Study With Bilastine | Biotech Hunter | Biotech Hunter